C-Src Protein Kinase Inhibitors Block Assembly and Maturation of Dengue Virus

Total Page:16

File Type:pdf, Size:1020Kb

C-Src Protein Kinase Inhibitors Block Assembly and Maturation of Dengue Virus c-Src protein kinase inhibitors block assembly and maturation of dengue virus J. J. H. Chu and Priscilla L. Yang* Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115 Communicated by John J. Mekalanos, Harvard Medical School, Boston, MA, December 29, 2006 (received for review December 19, 2006) Dengue virus is a mosquito-borne flavivirus that represents an intervention points for treatment of DENV infection. Although important emerging infectious disease and is an international extensive studies have been carried out over the years to health concern. Currently, there is no vaccine or effective antiviral understand the pathogenicity of DENV infection, little progress therapy to prevent or to treat dengue virus infection. The slow has been made in the development of specific anti-DENV progress in developing antiviral agents might be alleviated by the compounds. Currently, there are no specific treatments for availability of efficient high-throughput anti-dengue virus screen- DENV infection, and vaccines are unavailable. ing assays. In this study, we report an immunofluorescence image- In this article, we report the development of a microscopy-based based assay suitable for identification of small molecule inhibitors immunofluorescence assay that allows screening for small mole- of dengue virus infection and replication. Using this assay, we have cules that inhibit any step(s) in the DENV replication cycle, discovered that inhibitors of the c-Src protein kinase exhibit a including entry, viral RNA replication, and virion assembly and potent inhibitory effect on dengue virus (serotypes 1–4) and secretion. Phosphorylation of proteins by kinases is responsible for murine flavivirus Modoc. Mechanism of action studies demon- the transmission of biochemical signals in many signal transduction strated that the c-Src protein kinase inhibitor dasatinib prevents pathways, including those promoting cell survival (6, 7) and im- the assembly of dengue virions within the virus-induced membra- mune evasion (8, 9) during DENV infection as well as those nous replication complex. These results demonstrate that this regulating endocytosis of other viruses (10). In addition, phosphor- cell-based screen may provide a powerful means to identify new ylation of viral proteins such as DENV NS5 (11, 12) by cellular potential targets for anti-dengue drug development while simul- kinases is known to regulate their subcellular localization and, it is taneously providing pharmacological probes to investigate den- presumed, their functions. Hypothesizing that kinase inhibitors gue virus–host cell interactions at the biochemical level. Given the could be used to probe the impact of cellular kinases and their simplicity and excellent reproducibility of the assay, it should be associated signaling pathways on DENV infection and replication, useful in high-throughput screens of both small molecule and RNAi we screened a collection of 120 known inhibitors of mammalian libraries when implemented on a robotic image-based high- Ser/Thr and Tyr kinases. A number of the protein kinase inhibitors throughput screen (HTS) platform. Given the reasonable clinical were found to affect distinct steps in the DENV replication cycle safety of inhibitors such as dasatinib and AZD0530, inhibitors of and to cause multilog decreases in viral titer in the absence of c-Src protein kinase may have the potential to become a new class cytotoxicity. These findings provide pharmacological evidence that of anti-dengue viral therapeutic agents. host–cell kinase activity is essential for various stages of the DENV life cycle and may provide new insights for a possible anti-DENV antiviral ͉ chemical biology ͉ flavivirus ͉ small molecule inhibitor ͉ therapy. high-throughput screen Results engue virus (DENV) is an emerging mosquito-borne patho- Screen Development. In this study, a screen for small molecule Dgen that causes dengue fever (DF) and a severe life- inhibitors of DENV replication was developed to detect small threatening illness, dengue hemorrhagic fever/dengue shock molecules capable of interfering with the different step(s) of the syndrome (DHF/DSS) (1). DENV is a small, enveloped, posi- DENV replication cycle through their direct effects on viral gene tive-stranded RNA virus that belongs to the Flavivirus genus of products or through their interactions with cellular factors that the Flaviviridae family. Four distinct serotypes (DENV1 to -4) participate in viral processes. The image-based assay is based on the of dengue viruses are transmitted to humans through the bites of detection of DENV envelope protein and is outlined in supporting the mosquito species, Aedes aegypti and Aedes albopictus (2). It information (SI) Fig. 6. We first evaluated the ability of the assay has been estimated that Ϸ50–100 million cases of DF, and to quantitatively detect inhibition of DENV infection by a small Ϸ250,000–500,000 cases of DHF occur every year (3). Further- molecule, mycophenolic acid (MPA), which is known to inhibit the more, 2.5 billion of people are at risk for infection in subtropical viral RNA synthesis of DENV (13). Vero cells cultured in a 384-well and tropical regions of the world (4) in the absence of effective plate were first infected with DENV 2 at a multiplicity of infection intervention. The intracellular life cycle of DENV begins with (moi) of 1 and then incubated with different concentrations of receptor-mediated endocytosis of the virus into cells, followed by MPA. Three days after infection, cells were fixed and stained for fusion of the viral envelope protein with the late endosomal viral envelope protein (Env). Fig. 1A shows the reduction in the membrane, which results in the release of the viral genome into number of cells staining positively for DENV Env protein with the cytoplasm for replication. Replication of the viral RNA increasing concentrations of MPA treatment when compared with genome occurs within membrane-bound complexes formed from the endoplasmic reticulum membrane. Subsequently, virus particles are assembled and released via the host cell secretory Author contributions: P.L.Y. designed research; J.J.H.C. performed research; J.J.H.C. and machinery (5). Although replication of DENV involves complex P.L.Y. analyzed data; and J.J.H.C. and P.L.Y. wrote the paper. interaction between viral proteins and cellular factors, many of The authors declare no conflict of interest. these interactions remain unidentified and uncharacterized. Abbreviations: DENV, Dengue virus; MPA, mycophenolic acid; moi, multiplicity of infection. Small molecules that specifically target different steps in the viral *To whom correspondence should be addressed. E-mail: priscilla࿝[email protected]. replication cycle could potentially be used as ‘‘tool compounds’’ This article contains supporting information online at www.pnas.org/cgi/content/full/ to facilitate biochemical characterization of these host–virus 0611681104/DC1. interactions and might also be used to identify pharmacological © 2007 by The National Academy of Sciences of the USA 3520–3525 ͉ PNAS ͉ February 27, 2007 ͉ vol. 104 ͉ no. 9 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0611681104 Downloaded by guest on September 23, 2021 Screening of a Protein Kinase Inhibitor Library. With the hypothesis that kinase inhibitors can be used to unmask the cellular signal transduction pathways co-opted by DENV during its replication cycle, we used the immunofluorescence assay to screen a collection of over 120 inhibitors of mammalian Ser/Thr and Tyr kinases at concentrations predetermined to be noncytotoxic. The host cell target(s) reported to be affected by the members of the protein kinase panel are described in SI Table 2. This kinase inhibitor panel notably includes multiple distinct scaffold classes for many kinases, a feature intended to facilitate determination of which kinase is responsible for a particular anti-DENV effect. Employing a 50% reduction in the number of fluorescently stained DENV-infected cells as the criterion for further evaluation, inhibitors of seventeen protein kinases were identified (Table 1). Of the 44 different cellular kinases known to be targeted by our inhibitor collection, inhibition of cyclin-dependent (CDKs), JAK, casein (CK), Src-family, and epidermal growth factor receptor tyrosine (EGFRs) kinases was associated with anti-DENV activity. Fig. 1. Development of an image-based immunofluorescence assay for Notably, multiple compounds with inhibitory activity against Src- detection of DENV. (A) Detection of DENV infection of Vero cells using immunofluorescence staining for DENV envelope protein (Env) in the absence family, Bcr-Abl/c-Abl, c-Kit, and platelet-derived growth factor and presence of MPA. (B) Dosage-dependent inhibition of DENV 2 infection of receptor (PDGFR) kinases were associated with anti-DENV ac- cells treated with MPA. tivity and had diverse chemical structures (SI Table 3). Because kinase inhibitors (including the ones used in this study) often target multiple intracellular enzymes, we used the partially the untreated, DENV-infected cells. By using an automated mi- overlapping selectivities of these inhibitors to determine which croscope, the cytoplasmic green fluorescence and nuclear blue cellular kinases might actually be responsible for the observed fluorescence acquired from four randomly selected fields in each anti-DENV effects. An additional inhibitor, AZD0530 (K045), was well were imaged and the average number of DENV-infected cells
Recommended publications
  • Flavivirus: from Structure to Therapeutics Development
    life Review Flavivirus: From Structure to Therapeutics Development Rong Zhao 1,2,†, Meiyue Wang 1,2,†, Jing Cao 1,2, Jing Shen 1,2, Xin Zhou 3, Deping Wang 1,2,* and Jimin Cao 1,2,* 1 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China; [email protected] (R.Z.); [email protected] (M.W.); [email protected] (J.C.); [email protected] (J.S.) 2 Department of Physiology, Shanxi Medical University, Taiyuan 030001, China 3 Department of Medical Imaging, Shanxi Medical University, Taiyuan 030001, China; [email protected] * Correspondence: [email protected] (D.W.); [email protected] (J.C.) † These authors contributed equally to this work. Abstract: Flaviviruses are still a hidden threat to global human safety, as we are reminded by recent reports of dengue virus infections in Singapore and African-lineage-like Zika virus infections in Brazil. Therapeutic drugs or vaccines for flavivirus infections are in urgent need but are not well developed. The Flaviviridae family comprises a large group of enveloped viruses with a single-strand RNA genome of positive polarity. The genome of flavivirus encodes ten proteins, and each of them plays a different and important role in viral infection. In this review, we briefly summarized the major information of flavivirus and further introduced some strategies for the design and development of vaccines and anti-flavivirus compound drugs based on the structure of the viral proteins. There is no doubt that in the past few years, studies of antiviral drugs have achieved solid progress based on better understanding of the flavivirus biology.
    [Show full text]
  • The Molecular Characterization and the Generation of a Reverse Genetics System for Kyasanur Forest Disease Virus by Bradley
    The Molecular Characterization and the Generation of a Reverse Genetics System for Kyasanur Forest Disease Virus by Bradley William Michael Cook A Thesis submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fulfilment of the requirements of the degree of Master of Science Department of Microbiology University of Manitoba Winnipeg, Manitoba, Canada Copyright © 2010 by Bradley William Michael Cook 1 List of Abbreviations: AHFV - Alkhurma Hemorrhagic Fever Virus Amp – ampicillin APOIV - Apoi Virus ATP – adenosine tri-phosphate BAC – bacterial artificial chromosome BHK – Baby Hamster Kidney BSA – bovine serum albumin C1 – C-terminus fragment 1 C2 – C-terminus fragment 2 C - Capsid protein cDNA – comlementary Deoxyribonucleic acid CL – Containment Level CO2 – carbon dioxide cHP - capsid hairpin CNS - Central Nervous System CPE – cytopathic effect CS - complementary sequences DENV1-4 - Dengue Virus DIC - Disseminated Intravascular Coagulation (DIC) DNA – Deoxyribonucleic acid DTV - Deer Tick Virus 2 E - Envelope protein EDTA - ethylenediaminetetraacetic acid EM - Electron Microscopy EMCV – Encephalomyocarditis Virus ER - endoplasmic reticulum FBS – fetal bovine serum FP - fusion peptide GGEV - Greek Goat Encephalitis Virus GGYV - Gadgets Gully Virus GMP - Guanosine mono-phosphate GTP - Guanosine tri-phosphate HBV- Hepatitis B Virus HDV – Hepatitis Delta Virus HIV - Human Immunodeficiency Virus IFN – interferon IRES – internal ribosome entry sequence JEV - Japanese Encephalitis Virus KADV - Kadam Virus kDa -
    [Show full text]
  • Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives Ashok Munjal
    Old Dominion University ODU Digital Commons Bioelectrics Publications Frank Reidy Research Center for Bioelectrics 8-2017 Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives Ashok Munjal Rekha Khandia Kuldeep Dharma Swati Sachan Kumaragurubaran Karthik See next page for additional authors Follow this and additional works at: https://digitalcommons.odu.edu/bioelectrics_pubs Part of the Public Health Commons, Virology Commons, and the Virus Diseases Commons Repository Citation Munjal, Ashok; Khandia, Rekha; Dharma, Kuldeep; Sachan, Swati; Karthik, Kumaragurubaran; Tiwari, Ruchi; Malik, Yashpal S.; Kumar, Deepak; Singh, Raj K.; Iqbal, Hafiz M. N.; and Joshi, Sunil K., "Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives" (2017). Bioelectrics Publications. 132. https://digitalcommons.odu.edu/bioelectrics_pubs/132 Original Publication Citation Munjal, A., Khandia, R., Dhama, K., Sachan, S., Karthik, K., Tiwari, R., . Joshi, S. K. (2017). Advances in developing therapies to combat zika virus: Current knowledge and future perspectives. Frontiers in Microbiology, 8, 1469. doi:10.3389/fmicb.2017.01469 This Article is brought to you for free and open access by the Frank Reidy Research Center for Bioelectrics at ODU Digital Commons. It has been accepted for inclusion in Bioelectrics Publications by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. Authors Ashok Munjal, Rekha Khandia, Kuldeep Dharma,
    [Show full text]
  • Exploratory Re-Encoding of Yellow Fever Virus Genome: New In- Sights for the Design of Live-Attenuated Viruses
    bioRxiv preprint doi: https://doi.org/10.1101/256610; this version posted May 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Exploratory re-encoding of Yellow Fever Virus genome: new in- sights for the design of live-attenuated viruses Short title: Exploratory re-encoding of Yellow Fever Virus genome R. Klitting1*, T. Riziki1, G. Moureau1, G. Piorkowski1, E. A. Gould1, X. de Lamballerie1 1Unité des Virus Émergents (UVE: Aix-Marseille Univ – IRD 190 – Inserm 1207 – IHU Méditerranée Infection), Marseille, France *Corresponding Author E-mail: [email protected] (RK) bioRxiv preprint doi: https://doi.org/10.1101/256610; this version posted May 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Virus attenuation by genome re-encoding is a pioneering approach for generating effective live-attenuated vaccine candidates. Its core principle is to introduce a large number of synonymous substitutions into the viral genome to produce stable attenuation of the targeted virus. Introduction of large numbers of mutations has also been shown to maintain stability of the attenuated phenotype by lowering the risk of reversion and recombination of re-encoded genomes. Identifying mutations with low fitness cost is pivotal as this increases the number that can be introduced and generates more stable and attenuated viruses. Here, we sought to identify mutations with low deleterious impact on the in vivo replication and virulence of yellow fever virus (YFV).
    [Show full text]
  • Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence
    crossmark Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence Alexander J. McAuley,a,b Maricela Torres,a Jessica A. Plante,b,c* Claire Y.-H. Huang,d Dennis A. Bente,a,b,e,f David W. C. Beasleya,b,e,f Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USAa; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USAb; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USAc; Arbovirus Diseases Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Fort Collins, Colorado, USAd; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, USAe; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas, USAf ABSTRACT Flaviviruses are positive-sense, single-stranded RNA viruses responsible for millions of human infections annually. The enve- lope (E) protein of flaviviruses comprises three structural domains, of which domain III (EIII) represents a discrete subunit. The EIII gene sequence typically encodes epitopes recognized by virus-specific, potently neutralizing antibodies, and EIII is believed to play a major role in receptor binding. In order to assess potential interactions between EIII and the remainder of the E protein and to assess the effects of EIII sequence substitutions on the antigenicity, growth, and virulence of a representative flavivirus, chimeric viruses were generated using the West Nile virus (WNV) infectious clone, into which EIIIs from nine flaviviruses with various levels of genetic diversity from WNV were substituted.
    [Show full text]
  • Generation of a Lineage II Powassan Virus (Deer Tick Virus) Cdna Clone: Assessment of Flaviviral Genetic Determinants of Tick and Mosquito Vector Competence
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Vector Borne Manuscript Author Zoonotic Dis Manuscript Author . Author manuscript; available in PMC 2019 July 01. Published in final edited form as: Vector Borne Zoonotic Dis. 2018 July ; 18(7): 371–381. doi:10.1089/vbz.2017.2224. Generation of a Lineage II Powassan Virus (Deer Tick Virus) cDNA Clone: Assessment of Flaviviral Genetic Determinants of Tick and Mosquito Vector Competence Joan L. Kenney1, Michael Anishchenko1, Meghan Hermance2, Hannah Romo1, Ching-I Chen3, Saravanan Thangamani2, and Aaron C. Brault1 1Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 2Department of Pathology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas 3Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, California Abstract The Flavivirus genus comprises a diverse group of viruses that utilize a wide range of vertebrate hosts and arthropod vectors. The genus includes viruses that are transmitted solely by mosquitoes or vertebrate hosts as well as viruses that alternate transmission between mosquitoes or ticks and vertebrates. Nevertheless, the viral genetic determinants that dictate these unique flaviviral host and vector specificities have been poorly characterized. In this report, a cDNA clone of a flavivirus that is transmitted between ticks and vertebrates (Powassan lineage II, deer tick virus [DTV]) was generated and chimeric viruses between the mosquito/vertebrate flavivirus, West Nile virus (WNV), were constructed. These chimeric viruses expressed the prM and E genes of either WNV or DTV in the heterologous nonstructural (NS) backbone. Recombinant chimeric viruses rescued from cDNAs were characterized for their capacity to grow in vertebrate and arthropod (mosquito and tick) cells as well as for in vivo vector competence in mosquitoes and ticks.
    [Show full text]
  • Flaviviridae; Flavivirus) in Persistently Infected Hamsters
    Am. J. Trop. Med. Hyg., 88(3), 2013, pp. 455–460 doi:10.4269/ajtmh.12-0110 Copyright © 2013 by The American Society of Tropical Medicine and Hygiene Pathogenesis of Modoc Virus (Flaviviridae; Flavivirus) in Persistently Infected Hamsters A. Paige Adams,* Amelia P. A. Travassos da Rosa, Marcio R. Nunes, Shu-Yuan Xiao, and Robert B. Tesh Center for Biodefense and Emerging Infectious Diseases and Department of Pathology, University of Texas Medical Branch, Galveston, Texas Abstract. The long-term persistence of Modoc virus (MODV) infection was investigated in a hamster model. Golden hamsters (Mesocricetus auratus) were infected by subcutaneous inoculation with MODV, in which fatal encephalitis developed in 12.5% (2 of 16). Surviving hamsters shed infectious MODV in their urine during the first five months after infection, and infectious MODV was recovered by co-cultivation of kidney tissue up to eight months after infection. There were no histopathologic changes observed in the kidneys despite detection of viral antigen for 250 days after infection. Mild inflammation and neuronal degeneration in the central nervous system were the primary lesions observed during early infection. These findings confirm previous reports of persistent flavivirus infection in animals and suggest a mechanism for the maintenance of MODV in nature. INTRODUCTION Recent reports of chronic infection with a number of differ- – ent flaviviruses7 11 has renewed interest in the subject of Modoc virus (MODV) is a rodent-associated flavivirus that persistent flavivirus infection and the role it might play in has no known arthropod vector. Taxonomically, it is included virus maintenance and pathogenesis in the vertebrate host.
    [Show full text]
  • Yellow Fever in a Traveller Returning from Suriname to the Netherlands, March 2017
    Rapid communications Yellow fever in a traveller returning from Suriname to the Netherlands, March 2017 M Wouthuyzen-Bakker 1 2 , M Knoester 2 3 , AP van den Berg ⁴ , CH GeurtsvanKessel ⁵ , MP Koopmans ⁵ , C Van Leer-Buter ³ , B Oude Velthuis ⁶ , SD Pas ⁵ , WL Ruijs ⁷ , J Schmidt-Chanasit 8 9 , SG Vreden 10 , TS van der Werf ¹ , CB Reusken ⁵ , WF Bierman ¹ 1. University of Groningen, University Medical Center Groningen, Department of Internal Medicine / Infectious Diseases, Groningen, The Netherlands 2. These authors contributed equally to this work 3. University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, The Netherlands 4. University of Groningen, University Medical Center Groningen, Department of Gastroenterology & Hepatology, Groningen, The Netherlands 5. Erasmus MC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Rotterdam, The Netherlands 6. University of Groningen, University Medical Center Groningen, Department of Critical Care, Groningen, The Netherlands 7. National Coordination Centre for Communicable Disease Control, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands 8. Bernhard Nocht Institute for Tropical Medicine, WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Hamburg, Germany 9. German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany 10. Academic Hospital Paramaribo, Department of Internal Medicine and Infectious Diseases, Paramaribo, Suriname Correspondence: Wouter FW Bierman ([email protected]) Citation style for this article: Wouthuyzen-Bakker M, Knoester M, van den Berg AP, GeurtsvanKessel CH, Koopmans MP, Van Leer-Buter C, Oude Velthuis B, Pas SD, Ruijs WL, Schmidt-Chanasit J, Vreden SG, van der Werf TS, Reusken CB, Bierman WF.
    [Show full text]
  • Flavivirus Infectious Clones Issue Date: 2013-11-06 Construction, Characterization and Application of Flavivirus Infectious Clones
    Cover Page The handle http://hdl.handle.net/1887/22114 holds various files of this Leiden University dissertation Author: Jiang, Xiaohong Title: Construction characterization and application of Flavivirus infectious clones Issue Date: 2013-11-06 Construction, Characterization and Application of Flavivirus Infectious Clones Xiaohong Jiang ISBN: 978-90-8891-733-2 Cover design: Xiaohong Jiang, Joe Zhou and Kerry Zhang (K&A Inc.) The image on the front cover is a schematic representation of the landmarks in Shanghai, China, which is sketched out by the use of predicted RNA structural elements in the 3’-UTR of flaviviruses as illustrated in the thesis. Layout and printing: Proefschriftmaken.nl || Uitgeverij BOXPress Published by: Uitgeverij BOXPress, ’s-Hertogenbosch Construction, Characterization and Application of Flavivirus Infectious Clones Proefschrift ter verkrijging van de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof. mr. C.J.J.M. Stolker, volgens besluit van het College voor Promoties te verdedigen op woensdag 6 november 2013 klokke 11:15 uur door Xiaohong Jiang geboren te Shanghai, China in 1983 PROMOTIECOMMISSIE Promotor: Prof. Dr. W.J.M. Spaan Copromotor: Dr. P.J. Bredenbeek Overige leden: Prof. Dr. E.J. Snijder Prof. Dr. R.C. Hoeben Dr. D. Franco (Katholieke Universiteit Leuven) Prof. Dr. J.H. Neyts (Katholieke Universiteit Leuven) 献给我挚爱的父母 5 6 CONTENTS Chapter 1 General Introduction 9 Chapter 2 Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection
    [Show full text]
  • A Novel Model for the Study of the Therapy of Flavivirus Infections Using the Modoc Virus
    Virology 279, 27–37 (2001) doi:10.1006/viro.2000.0723, available online at http://www.idealibrary.com on CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector A Novel Model for the Study of the Therapy of Flavivirus Infections Using the Modoc Virus Pieter Leyssen,* Alfons Van Lommel,† Christian Drosten,‡ Herbert Schmitz,‡ Erik De Clercq,* and Johan Neyts*,1 *Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven B-3000, Belgium; †Division of Histopathology, University Hospitals, Leuven B-3000, Belgium; and ‡Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany Received May 31, 2000; returned to author for revision July 21, 2000; accepted October 26, 2000 The murine Flavivirus Modoc replicates well in Vero cells and appears to be as equally sensitive as both yellow fever and dengue fever virus to a selection of antiviral agents. Infection of SCID mice, by either the intracerebral, intraperitoneal, or intranasal route, results in 100% mortality. Immunocompetent mice and hamsters proved to be susceptible to the virus only when inoculated via the intranasal or intracerebral route. Animals ultimately die of (histologically proven) encephalitis with features similar to Flavivirus encephalitis in man. Viral RNA was detected in the brain, spleen, and salivary glands of infected SCID mice and the brain, lung, kidney, and salivary glands of infected hamsters. In SCID mice, the interferon inducer poly IC protected against Modoc virus-induced morbidity and mortality and this protection was associated with a reduction in infectious virus content and viral RNA load. Infected hamsters shed the virus in the urine. This allows daily monitoring of (inhibition of) viral replication, by means of a noninvasive method and in the same animal.
    [Show full text]
  • Stress Responses in Flavivirus-Infected Cells: Activation of Unfolded Protein
    MINI REVIEW ARTICLE published: 03 June 2014 doi: 10.3389/fmicb.2014.00266 Stress responses in flavivirus-infected cells: activation of unfolded protein response and autophagy Ana-Belén Blázquez1, Estela Escribano-Romero1,Teresa Merino-Ramos1, Juan-Carlos Saiz1 and Miguel A. Martín-Acebes1,2 * 1 Departamento de Biotecnología, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Madrid, Spain 2 Departamento de Virología y Microbiología, Centro de Biología Molecular “Severo Ochoa”,Consejo Superior de Investigaciones Científicas – Universidad Autónoma de Madrid, Madrid, Spain Edited by: The Flavivirus is a genus of RNA viruses that includes multiple long known human, Shiu-Wan Chan, The University of animal, and zoonotic pathogens such as Dengue virus, yellow fever virus, West Nile Manchester, UK virus, or Japanese encephalitis virus, as well as other less known viruses that represent Reviewed by: potential threats for human and animal health such as Usutu or Zika viruses. Flavivirus Hengli Tang, Florida State University, USA replication is based on endoplasmic reticulum-derived structures. Membrane remodeling Sara Louise Cosby, Queen’s and accumulation of viral factors induce endoplasmic reticulum stress that results in University Belfast, UK activation of a cellular signaling response termed unfolded protein response (UPR), which *Correspondence: can be modulated by the viruses for their own benefit. Concomitant with the activation Miguel A. Martín-Acebes, of the UPR, an upregulation of the autophagic pathway in cells infected with different Departamento de Virología y Microbiología, Centro de Biología flaviviruses has also been described. This review addresses the current knowledge of Molecular “Severo Ochoa”,Consejo the relationship between endoplasmic reticulum stress, UPR, and autophagy in flavivirus- Superior de Investigaciones infected cells and the growing evidences for an involvement of these cellular pathways in Científicas – Universidad Autónoma de Madrid, Nicolas Cabrera 1, the replication and pathogenesis of these viruses.
    [Show full text]
  • Replication Cycle and Molecular Biology of the West Nile Virus
    Viruses 2014, 6, 13-53; doi:10.3390/v6010013 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Replication Cycle and Molecular Biology of the West Nile Virus Margo A. Brinton Department of Biology, Georgia State University, Atlanta, GA 30303, USA; E-Mail: [email protected]; Tel.: +1-404-413-5388; Fax: +1-404-413-5301 Received: 21 October 2013; in revised form: 12 December 2013 / Accepted: 12 December 2013 / Published: 27 December 2013 Abstract: West Nile virus (WNV) is a member of the genus Flavivirus in the family Flaviviridae. Flaviviruses replicate in the cytoplasm of infected cells and modify the host cell environment. Although much has been learned about virion structure and virion-endosomal membrane fusion, the cell receptor(s) used have not been definitively identified and little is known about the early stages of the virus replication cycle. Members of the genus Flavivirus differ from members of the two other genera of the family by the lack of a genomic internal ribosomal entry sequence and the creation of invaginations in the ER membrane rather than double-membrane vesicles that are used as the sites of exponential genome synthesis. The WNV genome 3' and 5' sequences that form the long distance RNA-RNA interaction required for minus strand initiation have been identified and contact sites on the 5' RNA stem loop for NS5 have been mapped. Structures obtained for many of the viral proteins have provided information relevant to their functions. Viral nonstructural protein interactions are complex and some may occur only in infected cells. Although interactions between many cellular proteins and virus components have been identified, the functions of most of these interactions have not been delineated.
    [Show full text]